Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724759 | SCV000228553 | uncertain significance | not provided | 2015-04-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724759 | SCV000237478 | likely benign | not provided | 2019-12-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087084 | SCV001020044 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326970 | SCV002629613 | likely benign | Cardiovascular phenotype | 2019-05-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000724759 | SCV004237395 | uncertain significance | not provided | 2023-06-09 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000724759 | SCV001744603 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000259188 | SCV001918717 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724759 | SCV001974534 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000724759 | SCV001977966 | likely benign | not provided | no assertion criteria provided | clinical testing |